VERTEX PHARMACEUTICALS INC / MA (VRTX) Capital expenditures 2016–2025
VERTEX PHARMACEUTICALS INC / MA (VRTX) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$437.6MFY2025 · since FY2016: $56.6M → $437.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $437.6M | +47.0% |
| FY2024 | $297.7M | +48.6% |
| FY2023 | $200.4M | -2.1% |
| FY2022 | $204.7M | -12.9% |
| FY2021 | $235.0M | -9.5% |
| FY2020 | $259.8M | +244.6% |
| FY2019 | $75.4M | -21.0% |
| FY2018 | $95.4M | -4.0% |
| FY2017 | $99.4M | +75.8% |
| FY2016 | $56.6M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice